{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:06:27Z","timestamp":1790823987380,"version":"4.1.0"},"reference-count":217,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.antiviral.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T18:51:17Z","timestamp":1414695077000},"page":"21-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia"],"prefix":"10.1016","volume":"114","author":[{"given":"G.","family":"Andrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Topalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"De Schutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.10.012_b0005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(01)00520-4","article-title":"Antiviral approaches for cancers related to Epstein\u2013Barr virus and human papillomavirus","volume":"2","author":"Abdulkarim","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0010","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1038\/sj.onc.1205006","article-title":"Antiviral agent cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers","volume":"21","author":"Abdulkarim","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2014.10.012_b0015","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/sj.onc.1206402","article-title":"Antiviral agent cidofovir decreases Epstein\u2013Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies","volume":"22","author":"Abdulkarim","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2014.10.012_b0020","doi-asserted-by":"crossref","first-page":"e5018","DOI":"10.1371\/journal.pone.0005018","article-title":"Novel anti-metastatic action of cidofovir mediated by inhibition of E6\/E7, CXCR4 and Rho\/ROCK signaling in HPV tumor cells","volume":"4","author":"Amine","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.10.012_b0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1667\/RR0423.1","article-title":"Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines","volume":"166","author":"Amine","year":"2006","journal-title":"Radiat. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-micro-092611-150154","article-title":"Large T antigens of polyomaviruses: amazing molecular machines","volume":"66","author":"An","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0035","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir activity against poxvirus infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2014.10.012_b0040","first-page":"523","article-title":"Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines","volume":"10","author":"Andrei","year":"1998","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0045","first-page":"533","article-title":"Inhibiting effects of cidofovir (HPMPC) on the growth of the human cervical carcinoma (SiHa) xenografts in athymic nude mice","volume":"10","author":"Andrei","year":"1998","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3727\/096504001108747855","article-title":"Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells","volume":"12","author":"Andrei","year":"2000","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/AAC.41.3.587","article-title":"Activities of various compounds against murine and primate polyomaviruses","volume":"41","author":"Andrei","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0560.2009.01352.x","article-title":"Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors","volume":"37","author":"Andres","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coviro.2012.05.007","article-title":"MCV and Merkel cell carcinoma: a molecular success story","volume":"2","author":"Arora","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/0-387-32957-9_4","article-title":"Virus receptors and tropism","volume":"577","author":"Ashok","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.semcancer.2009.03.001","article-title":"Polyoma virus and simian virus 40 as cancer models: history and perspectives","volume":"19","author":"Atkin","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrneph.2011.59","article-title":"BK polyomavirus infection and nephropathy: the virus-immune system interplay","volume":"7","author":"Babel","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0085","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1074\/jbc.M110.197574","article-title":"Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes","volume":"286","author":"Banerjee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.012_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/jmbi.1996.0317","article-title":"Conserved features in papillomavirus and polyomavirus capsids","volume":"259","author":"Belnap","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.micinf.2012.02.002","article-title":"BK polyomavirus: emerging pathogen","volume":"14","author":"Bennett","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2014.10.012_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2013.07.020","article-title":"The E1 proteins","volume":"445","author":"Bergvall","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b1085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0110","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1600-6143.2008.02269.x","article-title":"Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression","volume":"8","author":"Bernhoff","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2014.10.012_b0115","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.01603-10","article-title":"Role of cathepsin A and lysosomes in the intracellular activation of novel antipapillomavirus agent GS-9191","volume":"55","author":"Birkus","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2010.10.002","article-title":"Persistence of human papillomavirus infection: keys to malignant progression","volume":"19","author":"Bodily","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0125","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1432-2277.2006.00430.x","article-title":"Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients","volume":"20","author":"Bonatti","year":"2007","journal-title":"Transpl. Int."},{"key":"10.1016\/j.antiviral.2014.10.012_b0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0135","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0190-9622(03)00870-3","article-title":"Topical cidofovir for condylomata acuminata of the genitalia in a 3-year-old child","volume":"49","author":"Calisto","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0140","doi-asserted-by":"crossref","first-page":"12744","DOI":"10.1073\/pnas.1303526110","article-title":"Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes","volume":"110","author":"Carter","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.10.012_b0145","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/bmt.2012.247","article-title":"Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"48","author":"Cesaro","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2014.10.012_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathol-011110-130227","article-title":"Merkel cell carcinoma: a virus-induced human cancer","volume":"7","author":"Chang","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.semcancer.2009.03.002","article-title":"Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens","volume":"19","author":"Cheng","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1090","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012997","article-title":"Human papillomavirus infections warts or cancer?","volume":"5","author":"Chow","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0165","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0463.2010.02625.x","article-title":"The natural history of human papillomavirus infections of the mucosal epithelia","volume":"118","author":"Chow","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2014.06.001","article-title":"Formulation of cidofovir improves the anti-papillomaviral activity of topical treatments in the CRPV\/rabbit model","volume":"108","author":"Christensen","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0175","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0026-895X(25)09608-7","article-title":"Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells","volume":"50","author":"Cihlar","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0180","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"10.1016\/j.antiviral.2014.10.012_b0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0190","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.joms.2010.10.040","article-title":"Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir","volume":"69","author":"Collette","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.antiviral.2014.10.012_b0195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0006-2952(99)00138-0","article-title":"9-(2-Phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG)","volume":"58","author":"Compton","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0200","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/14656560902960154","article-title":"Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions","volume":"10","author":"Coremans","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/jclinpath-2011-200330","article-title":"Transcriptional analysis of human papillomavirus type 16 in histological sections of cervical dysplasia by in situ hybridisation","volume":"65","author":"Coupe","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2013.06.007","article-title":"Diseases associated with human papillomavirus infection","volume":"445","author":"Cubie","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-199936020-00004","article-title":"Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir","volume":"36","author":"Cundy","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.antiviral.2014.10.012_b0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0090-9556(25)07424-0","article-title":"Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats","volume":"24","author":"Cundy","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2014.10.012_b0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1874357901105010080","article-title":"Small molecule inhibitors of human papillomavirus protein\u2013protein interactions","volume":"5","author":"D\u2019Abramo","year":"2011","journal-title":"Open Virol. J."},{"key":"10.1016\/j.antiviral.2014.10.012_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2012.12.015","article-title":"Human polyomaviruses in disease and cancer","volume":"437","author":"Dalianis","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2010.04.024","article-title":"New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir","volume":"65","author":"Darwich","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2014.10.012_b1095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bcp.2006.09.014","article-title":"Acyclic nucleoside phosphonates: Past, present and future Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: The phosphonate bridge","volume":"73","author":"De Clercq","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2006.10.006","article-title":"The acyclic nucleoside phosphonates from inception to clinical use: historical perspective","volume":"75","author":"De Clercq","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcp.2011.03.027","article-title":"The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond","volume":"82","author":"De Clercq","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0260","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2014.10.012_b0265","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","article-title":"Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis","volume":"22","author":"De Luca","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0270","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1212\/WNL.52.4.891","article-title":"Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy","volume":"52","author":"De Luca","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0275","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00002030-200009290-00001","article-title":"Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy","volume":"14","author":"De Luca","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0280","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clineuro.2007.09.012","article-title":"Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis","volume":"110","author":"De Raedt","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.antiviral.2014.10.012_b1100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2012.10.036","article-title":"Cidofovir treatment improves the pathology caused by the growth of human papillomavirus-positive cervical carcinoma xenografts in athymic nude mice","volume":"329","author":"De Schutter","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.antiviral.2014.10.012_b1105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1476-4598-12-158","article-title":"Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir","volume":"12","author":"De Schutter","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-6-18","article-title":"Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage","volume":"6","author":"De Schutter","year":"2013","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.antiviral.2014.10.012_b0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0305","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/CAD.0b013e3283612a71","article-title":"The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines\u2019 in-vitro and in-vivo xenografts","volume":"24","author":"Deberne","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.antiviral.2014.10.012_b0310","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1038\/onc.2013.449","article-title":"Human papillomavirus type 16 E7 perturbs DREAM to promote cellular proliferation and mitotic gene expression","volume":"33","author":"DeCaprio","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2014.10.012_b0315","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrmicro2992","article-title":"A cornucopia of human polyomaviruses","volume":"11","author":"DeCaprio","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/lary.23673","article-title":"Current use of intralesional cidofovir for recurrent respiratory papillomatosis","volume":"123","author":"Derkay","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.antiviral.2014.10.012_b0325","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/MLG.0b013e31816a7135","article-title":"Recurrent respiratory papillomatosis: a review","volume":"118","author":"Derkay","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.antiviral.2014.10.012_b0330","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","article-title":"The E5 proteins","volume":"445","author":"DiMaio","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0335","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hed.20572","article-title":"Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis","volume":"29","author":"Donne","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.antiviral.2014.10.012_b0340","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hed.21043","article-title":"Cidofovir induces an increase in levels of low-risk and high-risk HPV E6","volume":"31","author":"Donne","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.antiviral.2014.10.012_b0345","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/352824a0","article-title":"Specific interaction between HPV-16 E1\u2013E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network","volume":"352","author":"Doorbar","year":"1991","journal-title":"Nature"},{"issue":"Suppl. 5","key":"10.1016\/j.antiviral.2014.10.012_b1110","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.10.012_b0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.11691","article-title":"Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins","volume":"109","author":"Duensing","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0360","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/apm.12104","article-title":"The novel human polyomaviruses HPyV6, 7, 9 and beyond","volume":"121","author":"Ehlers","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1086\/597827","article-title":"Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment","volume":"48","author":"Eisen","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.10.012_b1170","series-title":"DNA Tumor Viruses","first-page":"1","article-title":"Polyomavirus life cycle","author":"Fanning","year":"2009"},{"key":"10.1016\/j.antiviral.2014.10.012_b0375","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.TP.0000149338.97084.5F","article-title":"Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system","volume":"79","author":"Farasati","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2014.10.012_b1115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1099\/vir.0.048462-0","article-title":"From Stockholm to Malawi: recent developments in studying human polyomaviruses","volume":"94","author":"Feltkamp","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0385","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.10.012_b0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.2008.08947.x","article-title":"The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients","volume":"160","author":"Field","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virol.2009.12.026","article-title":"Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication","volume":"399","author":"Fradet-Turcotte","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0400","first-page":"745","article-title":"Acyclic nucleotide analogues suppress growth and induce apoptosis in human leukemia cell lines","volume":"14","author":"Franek","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0405","first-page":"1899","article-title":"Mutations in adenosine deaminase-like (ADAL) protein confer resistance to the antiproliferative agents N6-cyclopropyl-PMEDAP and GS-9219","volume":"33","author":"Frey","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0410","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1399-3062.2010.00513.x","article-title":"Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach","volume":"12","author":"Ganguly","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.10.012_b0415","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbmt.2009.12.009","article-title":"Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir","volume":"16","author":"Gaziev","year":"2010","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.antiviral.2014.10.012_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-009-0412-8","article-title":"The biological properties of E6 and E7 oncoproteins from human papillomaviruses","volume":"40","author":"Ghittoni","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.antiviral.2014.10.012_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(10)06001-X","article-title":"Update on human polyomaviruses and cancer","volume":"106","author":"Gjoerup","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0430","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2010.12.049","article-title":"Human papillomavirus-related genital disease in the immunocompromised host: Part II","volume":"66","author":"Gormley","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0435","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1128\/AAC.00046-11","article-title":"CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes","volume":"55","author":"Gosert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0440","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jocn.2008.07.091","article-title":"What lies beneath the tent? JC-virus cerebellar granule cell neuronopathy complicating sarcoidosis","volume":"16","author":"Granot","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.antiviral.2014.10.012_b0445","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00405-012-2221-2","article-title":"Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis","volume":"270","author":"Graupp","year":"2013","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0450","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1158\/1078-0432.CCR-13-1121","article-title":"Cidofovir: a novel antitumor agent for glioblastoma","volume":"19","author":"Hadaczek","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2010.06.006","article-title":"Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP","volume":"643","author":"Hajek","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0460","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.bcp.2005.06.007","article-title":"Inhibition of human telomerase by diphosphates of acyclic nucleoside phosphonates","volume":"70","author":"Hajek","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0465","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-2952(99)00091-X","article-title":"N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties","volume":"58","author":"Hatse","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0470","first-page":"435","article-title":"9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase","volume":"10","author":"Hatse","year":"1999","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.antiviral.2014.10.012_b0475","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1200\/JCO.2010.28.2186","article-title":"Human papillomaviruses as therapeutic targets in human cancer","volume":"29","author":"Hellner","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0480","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apm.12128","article-title":"The human JC polyomavirus (JCPyV): virological background and clinical implications","volume":"121","author":"Hirsch","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0485","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0026-895X(25)08828-5","article-title":"Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0490","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1158\/1535-7163.MCT-05-0200","article-title":"Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro","volume":"5","author":"Hostetler","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.antiviral.2014.10.012_b0495","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2008.11.017","article-title":"Papillomavirus E6 proteins","volume":"384","author":"Howie","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0500","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virol.2008.09.027","article-title":"The role of polyomaviruses in human disease","volume":"384","author":"Jiang","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0505","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00705-011-1008-x","article-title":"Taxonomical developments in the family Polyomaviridae","volume":"156","author":"Johne","year":"2011","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0510","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/AAC.43.5.1198","article-title":"Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine","volume":"43","author":"Johnson","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0515","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/AAC.47.6.2022-2026.2003","article-title":"Alpha interferon augments cidofovir\u2019s antiviral and antiproliferative activities","volume":"47","author":"Johnson","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0520","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaad.2011.06.026","article-title":"Detection of Merkel cell polyomavirus in cutaneous squamous cell carcinoma before occurrence of Merkel cell carcinoma","volume":"65","author":"Kaibuchi-Noda","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1120","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/apm.12092","article-title":"The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications","volume":"121","author":"Kazem","year":"2013","journal-title":"APMIS"},{"key":"10.1016\/j.antiviral.2014.10.012_b1125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcv.2011.11.007","article-title":"Trichodysplasia spinulosa is characterized by active polyomavirus infection","volume":"53","author":"Kazem","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0535","doi-asserted-by":"crossref","DOI":"10.7750\/BioDiscovery.2012.1.3","article-title":"Targeting ATM pathway for therapeutic intervention in cancer","author":"Khalil","year":"2012","journal-title":"BioDiscovery"},{"key":"10.1016\/j.antiviral.2014.10.012_b1175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20266","article-title":"The agnoprotein of polyomaviruses: a multifunctional auxiliary protein","volume":"204","author":"Khalili","year":"2005","journal-title":"J. cell. Physiol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0540","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jmv.1036","article-title":"Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir","volume":"64","author":"Koonsaeng","year":"2001","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0545","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcv.2012.09.003","article-title":"BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial transmission","volume":"56","author":"Koskenvuo","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0550","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/TP.0b013e31820f08d0","article-title":"Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report","volume":"91","author":"Kralund","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2014.10.012_b0555","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1074\/jbc.273.34.21966","article-title":"Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase delta and epsilon in vitro","volume":"273","author":"Kramata","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.012_b0560","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0026-895X(25)08978-3","article-title":"Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon","volume":"49","author":"Kramata","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0565","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0166-3542(90)90065-F","article-title":"Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethylguanine (PMEG)","volume":"14","author":"Kreider","year":"1990","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0570","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/0194599810395353","article-title":"Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis","volume":"144","author":"Ksiazek","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.antiviral.2014.10.012_b0575","doi-asserted-by":"crossref","first-page":"24058","DOI":"10.1016\/S0021-9258(19)51047-X","article-title":"Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts","volume":"269","author":"Kuo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.012_b0580","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrneph.2012.64","article-title":"Management of polyomavirus-associated nephropathy in renal transplant recipients","volume":"8","author":"Kuypers","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0585","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1600-6143.2005.00980.x","article-title":"Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients","volume":"5","author":"Kuypers","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2014.10.012_b1180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/tid.12136","article-title":"Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience","volume":"15","author":"Kwon","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.10.012_b0595","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1128\/AAC.01422-06","article-title":"Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains","volume":"51","author":"Lebeau","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0600","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0605","first-page":"2562","article-title":"Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir","volume":"58","author":"Liekens","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0610","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/mol.106.026559","article-title":"The nucleotide analog cidofovir suppresses basic fibroblast growth factor (FGF2) expression and signaling and induces apoptosis in FGF2-overexpressing endothelial cells","volume":"71","author":"Liekens","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0615","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1183>3.0.CO;2-K","article-title":"Potent inhibition of hemangiosarcoma development in mice by cidofovir","volume":"92","author":"Liekens","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0620","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1074\/jbc.275.9.6167","article-title":"HeLa cells are phenotypically limiting in cyclin E\/CDK2 for efficient human papillomavirus DNA replication","volume":"275","author":"Lin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.012_b0625","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1128\/MCB.22.18.6592-6604.2002","article-title":"Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein","volume":"22","author":"Lin","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0630","doi-asserted-by":"crossref","first-page":"27283","DOI":"10.1074\/jbc.270.45.27283","article-title":"The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication","volume":"270","author":"Liu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.10.012_b0635","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1345\/aph.1Q430","article-title":"Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis","volume":"46","author":"Mackey","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0640","doi-asserted-by":"crossref","first-page":"00247","DOI":"10.1128\/mBio.00247-13","article-title":"Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding","volume":"4","author":"Maginnis","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2014.10.012_b0645","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1517\/14728222.2013.832204","article-title":"HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers","volume":"17","author":"Manzo-Merino","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.antiviral.2014.10.012_b0650","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007435-200106000-00007","article-title":"Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons","volume":"28","author":"Matteelli","year":"2001","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.antiviral.2014.10.012_b0655","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jmv.23550","article-title":"First description of Merkel Cell polyomavirus DNA detection in a patient with Stevens-Johnson syndrome","volume":"85","author":"Maximova","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0660","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2013.06.006","article-title":"The papillomavirus E2 proteins","volume":"445","author":"McBride","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0665","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virusres.2009.06.008","article-title":"Oncogenic activities of human papillomaviruses","volume":"143","author":"McLaughlin-Drubin","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0670","first-page":"497","article-title":"Involvement of MAP kinases in the cytotoxicity of acyclic nucleoside phosphonates","volume":"32","author":"Mertlikova-Kaiserova","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0675","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2011.04.002","article-title":"Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG","volume":"82","author":"Mertlikova-Kaiserova","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0680","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s00405-012-2103-7","article-title":"The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis","volume":"269","author":"Mikolajczak","year":"2012","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0685","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/BJ20112017","article-title":"Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma","volume":"443","author":"Miller","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2014.10.012_b0690","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/tid.12014","article-title":"Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection","volume":"15","author":"Momper","year":"2013","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.10.012_b0695","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0700","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nrc2961","article-title":"Why do viruses cause cancer? Highlights of the first century of human tumour virology","volume":"10","author":"Moore","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0705","first-page":"195","article-title":"9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine: a novel prodrug of 9-(2-phosphonylmethoxyethyl)guanine with improved antitumor efficacy and selectivity in choriocarcinoma-bearing rats","volume":"11","author":"Naesens","year":"1999","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0710","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2377-10-32","article-title":"Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report","volume":"10","author":"Naess","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0715","doi-asserted-by":"crossref","first-page":"e1003688","DOI":"10.1371\/journal.ppat.1003688","article-title":"A structure-guided mutation in the major capsid protein retargets BK polyomavirus","volume":"9","author":"Neu","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.10.012_b0720","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1099\/vir.0.035352-0","article-title":"Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6\/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells","volume":"92","author":"Nor","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0725","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4149\/av_2013_04_447","article-title":"Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses","volume":"57","author":"Nor","year":"2013","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0730","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/rmv.714","article-title":"Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?","volume":"22","author":"Olthof","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bmt.1703704","article-title":"Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir","volume":"30","author":"Osorio","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.antiviral.2014.10.012_b0740","first-page":"3173","article-title":"9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP)\u2013a potential drug against hematological malignancies\u2013induces apoptosis","volume":"19","author":"Otova","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0745","first-page":"1295","article-title":"In vivo modulation of angiogenic gene expression by acyclic nucleoside phosphonates PMEDAP and PMEG","volume":"29","author":"Otova","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0750","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/rheumatology\/kem049","article-title":"Progressive multifocal leucoencephalopathy in a patient with sarcoidosis \u2013 successful treatment with cidofovir and mirtazapine","volume":"46","author":"Owczarczyk","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.antiviral.2014.10.012_b0755","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1182\/blood-2010-02-269829","article-title":"Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells","volume":"116","author":"Pantulu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2014.10.012_b0760","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000333780","article-title":"Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient","volume":"3","author":"Park","year":"2011","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1140","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00812-13","article-title":"A divergent variant of the eleventh human polyomavirus species, saint louis polyomavirus","volume":"1","author":"Pastrana","year":"2013","journal-title":"Genome Announc."},{"key":"10.1016\/j.antiviral.2014.10.012_b0770","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0463.2010.02618.x","article-title":"Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs. low-risk human papillomaviruses","volume":"118","author":"Pim","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0775","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1124\/mol.52.1.63","article-title":"Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication","volume":"52","author":"Pisarev","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0780","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1386-6532(99)00069-4","article-title":"No apparent effect of cidofovir in epidermodysplasia verruciformis","volume":"16","author":"Preiser","year":"2000","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0785","doi-asserted-by":"crossref","first-page":"e1002116","DOI":"10.1371\/journal.ppat.1002116","article-title":"The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral release","volume":"7","author":"Raghava","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.10.012_b0790","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1021\/bi400036z","article-title":"SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release","volume":"52","author":"Raghava","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2014.10.012_b0795","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.virol.2013.05.007","article-title":"Animal papillomaviruses","volume":"445","author":"Rector","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0800","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2133.2000.03769.x","article-title":"Cidofovir inhibits growth of B16 melanoma cells in vivo","volume":"143","author":"Redondo","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0805","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1158\/1078-0432.CCR-07-2061","article-title":"GS-9219 \u2013 a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin\u2019s lymphoma","volume":"14","author":"Reiser","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0810","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaad.2009.08.064","article-title":"Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma","volume":"63","author":"Reisinger","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0815","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.27821","article-title":"Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm","volume":"132","author":"Rietbergen","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2014.10.012_b0820","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00974-10","article-title":"1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells","volume":"54","author":"Rinaldo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0825","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2010.3549","article-title":"Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option","volume":"2011","author":"Ripellino","year":"2011","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.antiviral.2014.10.012_b0830","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1172\/JCI64116","article-title":"Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus","volume":"122","author":"Rodig","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.10.012_b0835","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1055-9965.EPI-11-0764","article-title":"Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma","volume":"21","author":"Rollison","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.antiviral.2014.10.012_b0840","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jnci\/82.6.510","article-title":"In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]-guanine and related phosphonate nucleotide analogues","volume":"82","author":"Rose","year":"1990","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.antiviral.2014.10.012_b0845","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.022","article-title":"Structure, attachment and entry of polyoma- and papillomaviruses","volume":"384","author":"Sapp","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0850","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bmt.1705678","article-title":"Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant","volume":"39","author":"Savona","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.antiviral.2014.10.012_b0855","doi-asserted-by":"crossref","first-page":"16272","DOI":"10.1073\/pnas.0806526105","article-title":"T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus","volume":"105","author":"Shuda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.10.012_b0860","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/322593","article-title":"Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection","volume":"33","author":"Snoeck","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.10.012_b0865","first-page":"1561","article-title":"Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients","volume":"3","author":"Snoeck","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2014.10.012_b0870","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-9071(200002)60:2<205::AID-JMV16>3.0.CO;2-8","article-title":"Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III)","volume":"60","author":"Snoeck","year":"2000","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0875","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM199510053331418","article-title":"Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue","volume":"333","author":"Snoeck","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.10.012_b0880","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1096-9071(199803)54:3<219::AID-JMV13>3.0.CO;2-C","article-title":"Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]","volume":"54","author":"Snoeck","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0885","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2012.09.029","article-title":"Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential","volume":"435","author":"Spurgeon","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.10.012_b0890","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2014.10.012_b0895","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1042\/BST0351456","article-title":"HPV: from infection to cancer","volume":"35","author":"Stanley","year":"2007","journal-title":"Biochem. Soc. Trans."},{"issue":"Suppl. 5","key":"10.1016\/j.antiviral.2014.10.012_b1145","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","article-title":"Therapy of human papillomavirus-related disease","volume":"30","author":"Stern","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.10.012_b0905","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAD.0b013e32835a9b16","article-title":"Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women","volume":"27","author":"Stier","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0910","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","article-title":"Human papillomavirus type 16 and 18 gene expression in cervical neoplasias","volume":"23","author":"Stoler","year":"1992","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0915","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jmv.2213","article-title":"Local treatment of HPV-induced skin lesions by cidofovir","volume":"67","author":"Stragier","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0920","doi-asserted-by":"crossref","first-page":"e1000801","DOI":"10.1371\/journal.ppat.1000801","article-title":"The human polyoma JC virus agnoprotein acts as a viroporin","volume":"6","author":"Suzuki","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.10.012_b0925","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0463.2010.02620.x","article-title":"Current concepts on human papillomavirus infections in children","volume":"118","author":"Syrjanen","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.antiviral.2014.10.012_b0930","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1746-6148-10-30","article-title":"GS-9219\/VDC-1","volume":"10","author":"Thamm","year":"2014","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b1150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00405-011-1804-7","article-title":"Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide(R))","volume":"269","author":"Tjon Pian Gi","year":"2012","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1155","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00405-013-2358-7","article-title":"Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients","volume":"270","author":"Tjon Pian Gi","year":"2013","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0945","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2012.11.007","article-title":"The large tumor antigen: a \u201cSwiss Army knife\u201d protein possessing the functions required for the polyomavirus life cycle","volume":"97","author":"Topalis","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0950","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.01809-10","article-title":"Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells","volume":"55","author":"Topalis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b0955","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature11758","article-title":"Biochemistry: molecular hurdles cleared with ease","volume":"492","author":"Trakselis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.10.012_b0960","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ygyno.2005.07.127","article-title":"Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia","volume":"99","author":"Tristram","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0965","first-page":"177","article-title":"Cellular entry of polyomaviruses","volume":"343","author":"Tsai","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0970","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1158\/1078-0432.CCR-08-3113","article-title":"Assessment of GS-9219 in a pet dog model of non-Hodgkin\u2019s lymphoma","volume":"15","author":"Vail","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b0975","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000292582","article-title":"Antiproliferative effects of octadecyloxyethyl 9-[2-(phosphonomethoxy)ethyl]guanine against Me-180 human cervical cancer cells in vitro and in vivo","volume":"56","author":"Valiaeva","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.antiviral.2014.10.012_b1160","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2014.4385","article-title":"Cidofovir gel as treatment of follicular spicules in multiple myeloma","author":"van Boheemen","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0985","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jmv.1890450221","article-title":"Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine","volume":"45","author":"Van Cutsem","year":"1995","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b0990","doi-asserted-by":"crossref","first-page":"e1001024","DOI":"10.1371\/journal.ppat.1001024","article-title":"Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient","volume":"6","author":"van der Meijden","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.10.012_b0995","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/rmv.1711","article-title":"Genome analysis of the new human polyomaviruses","volume":"22","author":"Van Ghelue","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1000","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2009.06.042","article-title":"Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study","volume":"115","author":"Van Pachterbeke","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s15010-006-5103-y","article-title":"Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis","volume":"35","author":"Viallard","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2014.10.012_b1010","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/10428190500177995","article-title":"Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma","volume":"46","author":"Viallard","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.antiviral.2014.10.012_b1015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.clineuro.2007.05.009","article-title":"Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis","volume":"109","author":"Volker","year":"2007","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.antiviral.2014.10.012_b1020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archdermatol.2011.1413","article-title":"Viral-associated trichodysplasia: characterization of a novel polyomavirus infection with therapeutic insights","volume":"148","author":"Wanat","year":"2012","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1101\/gad.1735109","article-title":"Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes","volume":"23","author":"Wang","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.antiviral.2014.10.012_b1030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/JVI.78.2.821-833.2004","article-title":"Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1035","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/JVI.06243-11","article-title":"High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors","volume":"86","author":"Wetherill","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1040","doi-asserted-by":"crossref","first-page":"e1003206","DOI":"10.1371\/journal.ppat.1003206","article-title":"The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology","volume":"9","author":"White","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.10.012_b1045","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/AAC.00103-09","article-title":"GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions","volume":"53","author":"Wolfgang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b1050","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AAC.41.3.594","article-title":"Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation","volume":"41","author":"Xiong","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.10.012_b1055","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0006-2952(96)00100-1","article-title":"Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase","volume":"51","author":"Xiong","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3727\/096504010X12704916124909","article-title":"Effects of cidofovir on human papillomavirus-positive cervical cancer cells xenografts in nude mice","volume":"18","author":"Yang","year":"2010","journal-title":"Oncol. Res."},{"key":"10.1016\/j.antiviral.2014.10.012_b1065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature11730","article-title":"Bypass of a protein barrier by a replicative DNA helicase","volume":"492","author":"Yardimci","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.10.012_b1070","doi-asserted-by":"crossref","first-page":"e49449","DOI":"10.1371\/journal.pone.0049449","article-title":"Discovery of a novel polyomavirus in acute diarrheal samples from children","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.10.012_b1075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.605","article-title":"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins","volume":"19","author":"Yugawa","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.10.012_b1165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:51:35Z","timestamp":1746485495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":217,"alternative-id":["S0166354214003052"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}